Comprehensive surgical evaluation and treatment planning for cancers arising in the ureter and upper urinary tract, with treatment selected according to tumour location, stage, grade, kidney function and overall health.
The ureters are narrow muscular tubes that carry urine from each kidney to the urinary bladder. Cancer developing in the lining of the ureter is generally classified as an upper urinary tract urothelial cancer.
Most cancers of the renal pelvis and ureter are urothelial carcinomas. The disease can occur in different parts of the ureter and may vary in grade, depth of invasion and extent.
Treatment is not identical for every patient. Tumour location, size, grade, stage, kidney function, the condition of the opposite kidney and other health factors are considered when planning care.
Ureteral cancer belongs to the group of cancers affecting the urothelial lining of the upper urinary tract, including the renal pelvis and ureter.
Each kidney connects to the urinary bladder through a ureter. The location of a tumour can influence the surgical approach.
The upper portion of the ureter lies close to the kidney and continues downward from the renal pelvis.
The middle portion travels through the abdomen before continuing towards the pelvis.
The lower ureter travels through the pelvis and enters the urinary bladder.
The ureter enters the bladder at the ureterovesical junction, where tumours may require specific surgical consideration.
The most common type of cancer arising in the renal pelvis and ureter develops from the urothelial lining.
Some tumours have less aggressive microscopic features and may be considered for organ-preserving approaches in selected cases.
High-grade disease can have a greater risk of invasion and requires careful staging and treatment planning.
Tumours that extend deeper into the ureter wall may require more extensive surgery and multidisciplinary treatment planning.
Ureteral cancer may not always cause obvious symptoms in its early stages. Possible symptoms can include:
Visible or microscopic blood in the urine may be one of the presenting features.
Pain in the side or back may occur when urine flow is affected or when the tumour involves surrounding structures.
Changes in urination or urinary symptoms may occur and require appropriate evaluation.
Persistent urinary or abdominal symptoms should be assessed rather than assumed to have a single cause.
Diagnosis usually combines clinical evaluation, imaging and examination of the urinary tract. The exact investigations depend on the symptoms and suspected location of disease.
Ureteroscopy can allow direct examination of the ureter and may allow tissue sampling. Imaging is used to evaluate the urinary tract and look for local or distant disease.
Pathology from a biopsy or surgical specimen helps determine the tumour type and grade. Final treatment planning also considers staging and the patient's kidney function.
Urine testing, imaging such as CT-based studies, ureteroscopy, biopsy and additional staging investigations when clinically appropriate.
Urine tests may help investigate blood in the urine and other urinary abnormalities.
Imaging helps assess the kidneys, ureters, bladder and surrounding structures.
A thin scope may be passed through the urinary tract to inspect suspicious areas and obtain tissue when appropriate.
Tissue examination helps establish tumour type, grade and other features important for treatment planning.
Surgery is an important treatment for many localized ureteral cancers. The extent of surgery depends on the tumour and the patient's individual circumstances.
Nephroureterectomy removes the affected kidney and the entire ureter, together with a cuff of bladder tissue around the ureteral opening.
In selected patients, the cancer-containing portion of the ureter may be removed and the remaining ends reconstructed.
Organ-preserving approaches may be considered in carefully selected tumours, particularly when preserving kidney function is important.
Selected superficial tumours may be approached through the urinary tract using endoscopic techniques, including fulguration or laser treatment.
For many upper-tract urothelial cancers, removal of the kidney and entire ureter is the standard surgical approach when appropriate.
The operation generally includes removal of the affected kidney, the complete ureter and the portion of bladder surrounding the ureteral opening.
The decision depends on tumour location, stage, grade, kidney function and the condition of the opposite kidney.
The objective is to remove the involved upper urinary tract while maintaining appropriate cancer control based on the individual disease characteristics.
Kidney-sparing surgery is not appropriate for every ureteral tumour. It may be considered in selected situations where the disease characteristics make preservation reasonable.
The involved segment of the ureter is removed while preserving the remaining ureter and kidney when technically and oncologically appropriate.
The suitability of a kidney-sparing approach depends on tumour grade, stage, size, location, multifocality and overall renal function.
In selected superficial or lower-risk tumours, treatment may be performed through the urinary tract using ureteroscopic techniques.
Depending on the tumour, techniques such as tumour removal, fulguration or laser treatment may be considered.
These approaches require careful patient selection and close follow-up because upper-tract urothelial cancers can recur.
Endoscopic approaches can preserve the kidney in selected patients, but suitability depends on the characteristics of the tumour and the overall treatment plan.
Depending on tumour characteristics and the planned operation, nearby lymph nodes may also be evaluated or removed as part of cancer staging and treatment.
Ureteral cancers can spread to nearby lymph nodes, particularly with more advanced disease.
Lymph node assessment may provide additional information about the extent of disease.
Examination of removed tissue and lymph nodes can contribute to determining the final stage.
Surgery may be combined with other cancer treatments depending on tumour stage, grade, recurrence risk and the patient's overall condition.
Chemotherapy may be considered before or after surgery in selected patients depending on disease characteristics and treatment goals.
Regional chemotherapy or immunotherapy approaches may be considered in selected clinical situations.
When disease cannot be treated with surgery alone, systemic treatment may form an important part of the overall cancer plan.
Clinical trials may provide access to treatments being studied for upper-tract urothelial cancer.
There is no single surgical approach suitable for every ureteral cancer. Treatment planning considers multiple factors.
Establish the tumour type and relevant pathological features.
Assess tumour location, depth, stage and possible spread.
Evaluate both renal function and the condition of the opposite kidney.
Compare definitive surgery, kidney-sparing options and other treatments where appropriate.
Dr. Nitin Singhal is a surgical oncologist in Ahmedabad with experience in complex cancer surgery and multidisciplinary cancer care.
For ureteral and upper urinary tract cancers, treatment planning focuses on understanding the tumour, assessing its extent and selecting an appropriate surgical strategy for the individual patient.
Ureteral cancer is a relatively uncommon cancer involving the urinary tract between the kidney and bladder. Most cancers of the ureter are urothelial cancers and are grouped with cancers of the renal pelvis as upper-tract urothelial cancer.
Surgical treatment can range from kidney-sparing procedures in carefully selected patients to removal of the kidney and entire ureter with a bladder cuff. The appropriate procedure depends on the tumour's location, grade, stage, size, kidney function and other patient-specific factors.
Patients diagnosed with ureteral cancer may require a combination of surgery, pathology, imaging and oncology evaluation. Treatment can also involve systemic therapy or other approaches depending on the extent and characteristics of the disease.
If you have been diagnosed with a ureteral tumour or have been advised to undergo ureteral or upper urinary tract surgery, a specialist evaluation can help clarify the diagnosis, stage and available treatment options.
Common questions about ureteral cancer diagnosis, surgery and treatment planning.
Get a personalised evaluation to understand your diagnosis, tumour stage, surgical options and whether kidney-sparing or more extensive surgery may be appropriate for you.
Dr. Nitin Singhal has been recognised for his contribution to cancer care and surgical oncology, reflecting his commitment to advanced surgical techniques, clinical excellence and patient-centred care.
Surgical oncology training from Tata Memorial Hospital, Mumbai.
Expertise across complex and multidisciplinary cancer surgery.
Honoured for excellence in healthcare and surgical oncology.
Focus on evidence-based and personalised cancer treatment.
Recognition that reflects a continued commitment to excellence in cancer care.
